Medtech faces a critical operational challenge: commercializing products quickly while navigating medical, legal, and regulatory (MLR) teams. Due to the fundamental difference in product complexity, cross-functional stakeholder involvement, and regulatory requirements, adopting pharma models doesn’t work. Establishing MLR excellence in medtech is an evolution: moving from foundational governance and standardized workflows, to driving efficiency via reuse and analytics, to AI and automation integration. This approach transforms the MLR review process from a bottleneck into a strategic advantage. To overcome hurdles, medtechs need to consider three core pillars: Claims alignment Process integrity for every market Intentional content development
